These results suggest that TRIM21 promotes ferroptosis through the METTL3/SLC7A11 axis in pancreatic cancer and this axis may be a promising target for pancreatic cancer treatment. The gene discussed is SLC7A11; the disease is familial pancreatic carcinoma.